RxDoctor Payments DataLook up a doctor →

Shelly Howard, NP

Nurse Practitioner · Bristol, TNNPI 1962784603

Payments from drug & device makers

$18,681in general payments, 2019–2025

Across 1,028 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$1K
  • AbbVie$1K
  • AstraZeneca$1K
  • Neurelis, Inc.$1K
  • Novartis$1K
  • MDD US Operations, LLC$954
  • plus $12K from 52 others

What the payments were for

  • Speaking & faculty fees$250%
  • Food & beverage$18,56499%
  • Education$910%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.61$1,484
AbbVie(2 entities)106$1,278
AstraZeneca(2 entities)50$1,130
Neurelis, Inc.43$1,110
Novartis58$1,087
MDD US Operations, LLC51$954
Lundbeck LLC50$891
Biogen51$885
Genentech USA, Inc.32$635
Lilly USA, LLC35$580
Neurocrine Biosciences, Inc.27$524
Jazz Pharmaceuticals Inc.22$518
Pfizer46$495
Acadia Pharmaceuticals Inc35$473
Teva Pharmaceuticals USA, Inc.24$446
Eisai Inc.17$358
CSL Behring16$349
Amneal Pharmaceuticals LLC20$331
Johnson & Johnson13$330
TG Therapeutics, Inc.13$327
Biohaven Pharmaceuticals, Inc.14$282
Argenx US, Inc.11$279
Mallinckrodt Hospital Products Inc.11$255
Biohaven Pharmaceutical Holding Company Ltd.20$246
Amgen11$235
Impel Pharmaceuticals Inc.24$235
Sanofi12$234
Avanir Pharmaceuticals, Inc.12$220
Sunovion Pharmaceuticals Inc.18$201
Otsuka America Pharmaceutical, Inc.11$201
EMD Serono, Inc.15$195
Grifols USA, LLC8$162
Corium, LLC7$142
Sumitomo Pharma America, Inc.11$134
SK Life Science, Inc.6$134
Catalyst Pharmaceuticals, Inc.5$119
Arbor Pharmaceuticals, Inc.6$114
Bristol Myers Squibb6$110
Takeda Pharmaceuticals U.S.A., Inc.4$104
Vanda Pharmaceuticals Inc.4$97
Kyowa Kirin, Inc.5$97
Harmony Biosciences LLC3$76
Scilex Pharmaceuticals Inc.4$72
Tanabe Pharma America, Inc.4$71
Axsome Therapeutics, Inc.3$68
Supernus Pharmaceuticals, Inc.4$63
Alnylam Pharmaceuticals Inc.3$59
Merz Pharmaceuticals, LLC2$47
Adamas Pharmaceuticals, Inc.2$44
Sanofi-aventis U.S. LLC2$38
Sandoz2$38
Azurity Pharmaceuticals, Inc.2$32
Boston Scientific1$18
E.r. Squibb & Sons, L.L.C.1$18
Amylyx Pharmaceuticals, Inc.1$16
GE HealthCare1$15
Aprecia Pharmaceuticals, LLC1$12
Almatica Pharma LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,681 in reported general payments places this provider in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$46,780
Medicare patients
197
Services billed
480

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gamunex-CImmune Globul G/Gly/Iga Avg 4611$300,296
VyvgartEfgartigimod Alfa-Fcab14$264,448
MayzentSiponimod21$227,122
PrivigenImmun Glob G(Igg)/Pro/Iga 0-5013$175,560
Avonex Pen (4 Pack)Interferon Beta-1a15$143,865
RebifInterferon Beta-1a/Albumin13$136,106
NuplazidPimavanserin Tartrate15$74,379
Nurtec OdtRimegepant Sulfate42$58,263
Emgality PenGalcanezumab-Gnlm46$34,129
NuedextaDextromethorphan Hbr/Quinidine15$31,910
QuliptaAtogepant24$24,620
BotoxOnabotulinumtoxina17$22,470
Aimovig AutoinjectorErenumab-Aooe12$8,882
Gabapentin253$6,083
Carbidopa-LevodopaCarbidopa/Levodopa175$3,883

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Grifols USA, LLCGamunex-C$162$300,29611 claims
Argenx US, Inc.Vyvgart$279$264,44814 claims
NovartisMayzent$1,087$227,12221 claims
CSL BehringPrivigen$349$175,56013 claims
EMD Serono, Inc.Rebif$195$136,10613 claims
Acadia Pharmaceuticals IncNuplazid$473$74,37915 claims
PfizerNurtec Odt$495$58,26342 claims
AbbVieQulipta, Botox$1,278$47,09041 claims
Avanir Pharmaceuticals, Inc.Nuedexta$220$31,91015 claims
Amneal Pharmaceuticals LLCPyridostigmine Bromide$331$2,35227 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Bristol

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →